Floatz logo

Fludarabine

Lymphoma, Extranodal NK-T-Cell

National Cancer Institute (NCI)Small moleculePhase 2Active
B
59/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Lymphoma, Extranodal NK-T-Cell cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
International Extranodal Lymphoma Study Group (IELSG)
Phase 3BB
PREDNISONE TABLETS
Sun Yat-sen University
Phase 3BB
Eloxatin
Sun Yat-sen University
Phase 3BB
ETOPOSIDE
Sichuan University
Phase 3BB
Inno-206
Sun Yat-sen University
Phase 3BB

View all 24 →

Same molecule, other indications

Fludarabine is also rated in:

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →
Fanconi anemiaDormant
BBB
Indicative ·
76 / 100
View asset →
Recurrent Adult Diffuse Large Cell LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →